NTSR1 and endometrium adenocarcinoma: These results were confirmed in a series of 100 consecutive cases of endometrial adenocarcinoma, showing that high immunohistochemical expression of NTR1 was significantly correlated with shorter overall survival (p < 0.001) [24].